CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Journal of Clinical Research. 2024; 8: (2) ; 134-136 ; DOI: 10.12208/j.ijcr.20240070.

The application of domperidone in the treatment of chronic gastritis
多潘立酮在慢性胃炎治疗中的应用

作者: 王立新 *, 张秀锦

山东省肥城市安驾庄镇卫生院 山东肥城

*通讯作者: 王立新,单位:山东省肥城市安驾庄镇卫生院 山东肥城;

发布时间: 2024-02-23 总浏览量: 489

摘要

目的 分析慢性胃炎治疗中采取多潘立酮所体现的临床效果。方法 纳入我院2022年9月至2023年9月期间确诊医治的慢性胃炎患者,将全体96例患者随机划分两组,每组平均48例。对照组予雷尼替丁治疗,观察组予多潘立酮治疗。对两组患者临床治疗效果、炎症因子水平以及不良反应进行综合评价。结果 观察组总有效率较对照组提升更显著(P<0.05)。观察组治疗后CRP、IL-32、MCP-1水平较对照组下降更显著(P<0.05)。观察组不良反应发生率较对照组下降更显著(P<0.05)。结论 慢性胃炎采取多潘立酮的疗效更显著,可缓解炎症反应,有良好安全性。

关键词: 慢性胃炎;多潘立酮;炎症反应

Abstract

Objective To analyze the clinical effect of domperidone in the treatment of chronic gastritis.
Methods All 96 patients with chronic gastritis diagnosed and treated in our hospital from September 2022 to September 2023 were randomly divided into two groups, with an average of 48 cases in each group. The control group was treated with ranitidine and the observation group was treated with domperidone. The clinical therapeutic effect, inflammatory factor levels and adverse reactions of the two groups were comprehensively evaluated.
Results The total effective rate of the observation group was significantly higher than that of the control group (P < 0.05). The levels of CRP, IL-32 and MCP-1 in the observation group were significantly lower than those in the control group after treatment (P < 0.05). The incidence of adverse reactions in the observation group was significantly lower than that in the control group (P < 0.05).
Conclusion   Domperidone is more effective in chronic gastritis, which can relieve inflammation and has good safety.

Key words: Chronic gastritis; Domperidone; Inflammatory response

参考文献 References

[1] 肖本军,赵亮,瞿国义等.多潘立酮联合铝碳酸镁用于幽门螺杆菌阴性慢性糜烂性胃炎的疗效观察[J].大医生, 2023,8(17):51-53.

[2] 罗英润,罗科鸿,曾胜旺.多潘立酮联合奥美拉唑治疗慢性胃炎患者的效果[J].中国民康医学,2023,35(16):44-46.

[3] 董云南,曲晨,高承志等.替普瑞酮、奥美拉唑联合多潘立酮对慢性萎缩性胃炎疗效观察[J].潍坊医学院学报,2022, 44(6):465-467.

[4] 许秋菊,王友刚.多潘立酮联合铝碳酸镁在大学生急性单纯性胃炎治疗中的临床效果分析[J].北方药学,2022, 19 (6): 17-19.

[5] 中华医学会消化病学分会,中华医学会消化病学分会消化系统肿瘤协作组. 中国慢性胃炎诊治指南(2022年,上海)[J]. 中华消化杂志,2023,43(3):145-175. 

[6] 黄利娟.多潘立酮辅助治疗对内镜下均-胃黏膜颗粒样改变患者胃黏膜屏障功能的影响[J].疾病监测与控制, 2021,15(3):201-203.

[7] 张爱华,杨琳娜.艾司奥美拉唑、多潘立酮联合铝碳酸镁治疗胆汁反流性胃炎[J].实用中西医结合临床,2021,21 (11): 74-75.

[8] 杨晓彤.多潘立酮合旋复代赭汤治疗胆汁反流性胃炎的临床疗效观察[J].贵州中医药大学学报,2021,43(03):50-53.

[9] 林依娜,刘少康.健脾益胃化瘀汤联合多潘立酮治疗慢性胃炎中的疗效观察及对营养状态的影响[J].实用中医内科杂志,2021,35(09):110-113.

[10] 张彩英,邓智英,吴善瑜.益胃健脾汤加减联合奥美拉唑、多潘立酮治疗脾胃虚弱型慢性萎缩性胃炎的临床观察[J].中国民间疗法,2021,29(07):91-92.

引用本文

王立新, 张秀锦, 多潘立酮在慢性胃炎治疗中的应用[J]. 国际临床研究杂志, 2024; 8: (2) : 134-136.